3
Participants
Start Date
February 8, 2022
Primary Completion Date
January 4, 2024
Study Completion Date
November 15, 2024
Poly ICLC
Enrolled participants will receive poly-ICLC 20 mcg/kg/dose twice weekly IM (using Monday/Thursday or Tuesday/Friday schedule if possible).
New York University Medical Center (Site 200), New York
Children's Hospital of Philadelphia (Site 750), Philadelphia
Children's National Medical Center (Site 775), Washington D.C.
Children's Healthcare of Atlanta, Atlanta
The University of Alabama at Birmingham (Site 700), Birmingham
Children's Lurie Hospital, Chicago
Lurie Children's Hospital of Chicago (Site 350), Chicago
University of Chicago (Site 850), Chicago
Washington University - St. Louis (Site 900), St Louis
Childrens Medical Center - Univ. of Texas SW (Site 917), Dallas
Children's Hospital of Los Angeles, Los Angeles
Cincinnati Children's Hospital Medical Center (Site 800), Cincinnati
Collaborators (1)
Children's Healthcare of Atlanta
OTHER
Children's Hospital Los Angeles
OTHER
University of Alabama at Birmingham
OTHER